Meaning-Centered Psychotherapy in Advanced Cancer

Neoplasms Clinical Trial

Official title:

Meaning-Centered Psychotherapy in Advanced Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00067288
• Other study ID #: R21AT001031-01
• Secondary ID: Breitbart
• Status: Completed
• Phase: Phase 2
• First received: August 14, 2003
• Last updated: August 16, 2006
• Start date: May 2002
• Est. completion date: March 2006

Study information

• Verified date: August 2006
• Source: National Center for Complementary and Integrative Health (NCCIH)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.

Description:

As per Brief Summary

Recruitment information / eligibility

• Status: Completed
• Enrollment: 118
• Est. completion date: March 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• 21 years of age or older;

• English speaking;

• Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma;

• Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;

Exclusion Criteria:

• Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention;

• Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent;

• Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

• Lymphoma, Non-Hodgkin
• Neoplasms

Intervention

Behavioral:
• Meaning-Centered Group Psychotherapy

• Standard Supportive Group Psychotherapy

Locations

Country	Name	City	State
United States	Memorial Sloan-Kettering Institute for Cancer Research	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States,